Wa. Bax et al., [ARG(8)]VASOPRESSIN-INDUCED RESPONSES OF THE HUMAN ISOLATED CORONARY-ARTERY - EFFECTS OF NONPEPTIDE RECEPTOR ANTAGONISTS, European journal of pharmacology, 285(2), 1995, pp. 199-202
Contractions induced by [Arg(8)]vasopressin (vasopressin) and the effe
ct of nonpeptide vasopressin receptor antagonists were studied in the
human isolated coronary artery. Vasopressin induced contraction of cor
onary artery segments with a high pD(2) (9.25) but a low E(max) (11.8%
of the response to 100 mM K+). This response was not affected by remo
val of the endothelium. Contraction was antagonized by the vasopressin
V-1 receptor antagonist SR 49059 ((2S) 1-[(2R 3S)-5-chloro-3-(2-chlor
ophenyl)-1-(3, o-1H-indole-2-carbonyl]-pyrrolidine-2-carboxamide) (pA(
2): 9.76). OPC-31260 amino)benzoyl}-2,3,4,5-tetrahydro-1H-benazaepine]
: vasopressin V-2 receptor antagonist) and OPC-21268 (1-{1-[4-(3-acety
laminopropoxy) nzoyl]-4-piperidyl}-3,4-dihydro-2(1H)-quinolinone: repo
rted vasopressin V-2 receptor antagonist) were less potent antagonists
of vasopressin-induced contractions (pA(2): 7.31 and 5.6, respectivel
y). The antagonist potency order (SR 49059 > OPC-31260 > OPC-21268) co
rresponds to the reported affinity order for the human cloned vasopres
sin V-1 receptor. Therefore, the vasopressin V-1 receptor antagonist S
R 49059, but not OPC-21268, appears to be an appropriate tool to inves
tigate further the role of vasopressin in pathological processes invol
ving coronary vasoconstriction in humans.